Tuesday - February 10, 2026
Fresenius Medical Care Accelerates Second Tranche of Its EUR 1 Billion Share Buyback Program With Around EUR 415 Million Repurchase Planned
January 09, 2026
HOMBURG, Germany, Jan. 9 -- Fresenius Medical Care, a provider of products and services for people with chronic kidney failure, issued the following news release:

* * *

Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned

* The second tranche of the share buyback is expected to be executed by May 8, 2026

* The share buyback program with a total volume of . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products